In the past one year, Indoco Remedies slipped 20.83 per cent to Rs 267.35 till March 21, whereas the BSE Sensex plunged 10.31 per cent during the same period.
The plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments and 60 million capsules of hard gelatin
Posts net profit of Rs 20.3 crore compared to Rs 18.7 crore Indoco Remedies has planned an investment of Rs 125 crore for expansion of its sterile ophthalmic facility at Goa and for setting up a green field API facility at Pa
Board recommends dividend of Rs 1.60 per equity share During the quarter under review, the net revenues of Indoco Remedies grew by 13.8 per cent to Rs 211.6 crores as against Rs 185.9 crores for the same period last year. The